Editorial
From Dysbiosis to Dyshomeostasis: Why Parkinson’s Requires a Metallomic–Microbiome Lens
Pendergrass, K.. Microbiome Medicine Journal, Volume I, Issue I.
Editorial premise advancing a metallomic–microbiome framework in which metal dyshomeostasis, particularly iron mismanagement, initiates neuronal vulnerability and selects for pathogenic microbial ecologies in Parkinson’s disease.
Journal Article
Microbial Metallomics and Parkinson’s Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and α-Synuclein Pathology
Pendergrass, K.. Microbiome Medicine Journal, Volume I, Issue I.
Unifying framework positioning heavy metal dyshomeostasis as the initiating event connecting ferroptosis, microbial virulence, neuroinflammation, and α-synuclein pathology in Parkinson’s disease.
Roundtable Paper
Pheomelanin, Eumelanin, and Neuromelanin: A Metal-Linked Hypothesis for Parkinson’s Risk in Redheads
Eyer, K., Pendergrass, K.. Microbiome Medicine Roundtable, Volume I, Issue I.
Novel hypothesis proposing that MC1R loss-of-function variants alter neuromelanin composition toward pheomelanin dominance, reducing iron sequestration capacity and increasing ferroptosis susceptibility in dopaminergic neurons.
Roundtable Paper
Melanotan Peptides as Potential Therapeutics in Parkinson’s Disease
Pendergrass, K., Eyer, K.. Microbiome Medicine Roundtable, Volume I, Issue I.
Evaluates MC1R agonism (melanotan I/afamelanotide and melanotan II) as a metallomics-informed therapeutic strategy for Parkinson’s disease, proposing that MC1R activation biases pigment chemistry toward eumelanin and reduces iron-driven ferroptosis.
Journal Article
The Microbiome Medicine Roundtable Method: From Mechanism to Testable Intervention
Pendergrass, K.. Microbiome Medicine Journal, Volume I, Issue I.
Formal description of the Microbiome Medicine Roundtable as a structured, mechanism-first synthesis method for converting fragmented biomedical observations into coherent disease models and translational hypotheses.
Journal Article
Itraconazole and Lactoferrin for FIP-Associated Gingivitis in Cats: A Perspective
Pendergrass, K.. Zenodo.
Proposes itraconazole and lactoferrin as a combined intervention for FIP-associated gingivitis in cats, addressing polymicrobial biofilms involving Porphyromonas gingivalis and Candida albicans through drug repurposing, nutritional immunity, and microbial metallomics.
Database / Condition Page
Microbiome Signature of Endometriosis
Pendergrass, K., Aristotelous, G., Aleru, D., Eyer, K.. Microbiome Medicine.
Comprehensive condition page formalizing the microbiome signature of endometriosis with Major Microbial Associations, validated and promising interventions (HBOT, low-nickel diet, metronidazole), and STOP recommendations.
Database / Condition Page
The Microbiome Signature of Chronic Kidney Disease (CKD)
Pendergrass, K.. Microbiome Medicine.
Condition page documenting the microbiome signature of chronic kidney disease, including differentially abundant taxa, intervention candidates, and the role of site-specific prebiotic fibers in CKD management.
Conference Presentation
The Microbiome Signature of Endometriosis: From Dysbiosis to Metallomics to Targeted Interventions
Pendergrass, K.. 11th Beneficial Microbes Conference, Amsterdam.
Live demonstration of the Microbiome Signature Triangulation Method applied to endometriosis before an audience of 150 researchers. Included metallomic signature analysis, microbial functional profiling, and a STOP analysis challenging routine iron and zinc supplementation.